Hoang-Xuan K - Search Results

1

Ibrutinib monotherapy in relapsed/refractory CNS lymphoma: A retrospective case series.

Chamoun K, Choquet S, Boyle E, Houillier C, Larrieu-Ciron D, Al Jijakli A, Delrieu V, Delwail V, Morschhauser F, Hoang-Xuan K, Soussain C. Chamoun K, et al. Neurology. 2017 Jan 3;88(1):101-102. doi: 10.1212/WNL.0000000000003420. Epub 2016 Nov 18. Neurology. 2017. PMID: 27864520 No abstract available.

2

Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.

Soussain C, Suzan F, Hoang-Xuan K, Cassoux N, Levy V, Azar N, Belanger C, Achour E, Ribrag V, Gerber S, Delattre JY, Leblond V. Soussain C, et al. J Clin Oncol. 2001 Feb 1;19(3):742-9. doi: 10.1200/JCO.2001.19.3.742. J Clin Oncol. 2001. PMID: 11157026 Clinical Trial.

3

Seizure-related contrast enhancement of a ganglioglioma.

Laigle F, Martin-Duverneuil N, Carpentier A, Hoang-Xuan K, Delattre JY. Laigle F, et al. Neurology. 2002 May 28;58(10):1538. doi: 10.1212/wnl.58.10.1538. Neurology. 2002. PMID: 12034794 No abstract available.

4

[Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma].

Soussain C, Hoang-Xuan K, Levy V. Soussain C, et al. Bull Cancer. 2004 Feb;91(2):189-92. Bull Cancer. 2004. PMID: 15047459 Free article. French.

5

Correlations between molecular profile and radiologic pattern in oligodendroglial tumors.

Laigle-Donadey F, Martin-Duverneuil N, Lejeune J, Crinière E, Capelle L, Duffau H, Cornu P, Broët P, Kujas M, Mokhtari K, Carpentier A, Sanson M, Hoang-Xuan K, Thillet J, Delattre JY. Laigle-Donadey F, et al. Neurology. 2004 Dec 28;63(12):2360-2. doi: 10.1212/01.wnl.0000148642.26985.68. Neurology. 2004. PMID: 15623700 Review.

6

Recent advances in primary CNS lymphoma.

Hoang-Xuan K, Camilleri-Broët S, Soussain C. Hoang-Xuan K, et al. Curr Opin Oncol. 2004 Nov;16(6):601-6. doi: 10.1097/01.cco.0000142927.88773.7e. Curr Opin Oncol. 2004. PMID: 15627024 Review.

7

New treatment approaches in primary central nervous system lymphoma.

Soussain C, Hoang-Xuan K, Doolittle ND. Soussain C, et al. Hematol Oncol Clin North Am. 2005 Aug;19(4):719-28, vii. doi: 10.1016/j.hoc.2005.05.007. Hematol Oncol Clin North Am. 2005. PMID: 16083832 Review.

8

A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases.

Camilleri-Broët S, Crinière E, Broët P, Delwail V, Mokhtari K, Moreau A, Kujas M, Raphaël M, Iraqi W, Sautès-Fridman C, Colombat P, Hoang-Xuan K, Martin A. Camilleri-Broët S, et al. Blood. 2006 Jan 1;107(1):190-6. doi: 10.1182/blood-2005-03-1024. Epub 2005 Sep 8. Blood. 2006. PMID: 16150948 Free article.

9

Prognostic impact of molecular markers in a series of 220 primary glioblastomas.

Houillier C, Lejeune J, Benouaich-Amiel A, Laigle-Donadey F, Criniere E, Mokhtari K, Thillet J, Delattre JY, Hoang-Xuan K, Sanson M. Houillier C, et al. Cancer. 2006 May 15;106(10):2218-23. doi: 10.1002/cncr.21819. Cancer. 2006. PMID: 16568472 Free article.

10

Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.

Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F, Renard MA, Iraqi W, Idbaih A, Paris S, Capelle L, Duffau H, Cornu P, Simon JM, Mokhtari K, Polivka M, Omuro A, Carpentier A, Sanson M, Delattre JY, Hoang-Xuan K. Kaloshi G, et al. Neurology. 2007 May 22;68(21):1831-6. doi: 10.1212/01.wnl.0000262034.26310.a2. Neurology. 2007. PMID: 17515545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters